NO130179B - - Google Patents
Download PDFInfo
- Publication number
- NO130179B NO130179B NO70145A NO14570A NO130179B NO 130179 B NO130179 B NO 130179B NO 70145 A NO70145 A NO 70145A NO 14570 A NO14570 A NO 14570A NO 130179 B NO130179 B NO 130179B
- Authority
- NO
- Norway
- Prior art keywords
- mastitis
- serum
- immunoglobulin
- blood
- globulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA69333 | 1969-01-17 | ||
| ZA691780 | 1969-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO130179B true NO130179B (de) | 1974-07-22 |
Family
ID=27130988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO70145A NO130179B (de) | 1969-01-17 | 1970-01-15 |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT309134B (de) |
| BE (1) | BE744515A (de) |
| CA (1) | CA954045A (de) |
| CH (1) | CH560543A5 (de) |
| DE (1) | DE2001671C3 (de) |
| DK (1) | DK128981B (de) |
| ES (1) | ES375511A1 (de) |
| FR (1) | FR2034472B1 (de) |
| GB (1) | GB1297011A (de) |
| IE (1) | IE33944B1 (de) |
| IL (1) | IL33614A (de) |
| IT (1) | IT1044200B (de) |
| MT (1) | MTP639B (de) |
| NL (1) | NL164746C (de) |
| NO (1) | NO130179B (de) |
| OA (1) | OA03892A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL1019143C2 (nl) * | 2001-10-08 | 2003-04-09 | Nutricia Nv | Farmaceutisch product of voedingssupplement en daarbij te gebruiken tussenproduct. |
| RU2338375C2 (ru) * | 2006-09-04 | 2008-11-20 | Государственное образовательное учреждение высшего профессионального образования "Удмуртский государственный университет" | Способ хранения плазмы или сыворотки крови для получения иммуноглобулиновых и альбуминовых биопрепаратов |
-
1969
- 1969-12-26 IL IL33614A patent/IL33614A/en unknown
-
1970
- 1970-01-09 AT AT514671A patent/AT309134B/de not_active IP Right Cessation
- 1970-01-14 CH CH47670A patent/CH560543A5/de not_active IP Right Cessation
- 1970-01-14 MT MT639A patent/MTP639B/xx unknown
- 1970-01-15 NO NO70145A patent/NO130179B/no unknown
- 1970-01-15 DE DE2001671A patent/DE2001671C3/de not_active Expired
- 1970-01-16 FR FR7001552A patent/FR2034472B1/fr not_active Expired
- 1970-01-16 DK DK19270AA patent/DK128981B/da unknown
- 1970-01-16 CA CA072,282A patent/CA954045A/en not_active Expired
- 1970-01-16 IE IE62/70A patent/IE33944B1/xx unknown
- 1970-01-16 NL NL7000637.A patent/NL164746C/xx not_active IP Right Cessation
- 1970-01-16 BE BE744515D patent/BE744515A/xx not_active IP Right Cessation
- 1970-01-16 ES ES375511A patent/ES375511A1/es not_active Expired
- 1970-01-17 OA OA53835A patent/OA03892A/xx unknown
- 1970-01-17 IT IT47859/70A patent/IT1044200B/it active
- 1970-01-19 GB GB1297011D patent/GB1297011A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL164746C (nl) | 1981-02-16 |
| IE33944B1 (en) | 1974-12-11 |
| GB1297011A (de) | 1972-11-22 |
| DE2001671B2 (de) | 1980-09-25 |
| CA954045A (en) | 1974-09-03 |
| NL164746B (nl) | 1980-09-15 |
| IT1044200B (it) | 1980-03-20 |
| CH560543A5 (de) | 1975-04-15 |
| DK128981C (de) | 1975-01-20 |
| IL33614A (en) | 1973-08-29 |
| IE33944L (en) | 1970-07-17 |
| DE2001671A1 (de) | 1970-07-30 |
| OA03892A (fr) | 1975-08-14 |
| NL7000637A (de) | 1970-07-21 |
| DK128981B (da) | 1974-08-05 |
| IL33614A0 (en) | 1970-02-19 |
| MTP639B (en) | 1970-07-22 |
| AT309134B (de) | 1973-08-10 |
| BE744515A (fr) | 1970-07-01 |
| DE2001671C3 (de) | 1981-10-08 |
| FR2034472B1 (de) | 1974-03-22 |
| FR2034472A1 (de) | 1970-12-11 |
| ES375511A1 (es) | 1973-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guterbock et al. | Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens | |
| Hill et al. | The elimination of serum-resistant Escherichia coli from experimentally infected single mammary glands of healthy cows | |
| US3376198A (en) | Method of producing antibodies in milk | |
| US3128230A (en) | Milk having antibodies therein and process for producing same | |
| US5585098A (en) | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants | |
| Smith et al. | Mastitis and other diseases of the goat's udder | |
| Griel Jr et al. | Clinical and clinico-pathological effects of Escherichia coli endotoxin in mature cattle | |
| Ziv et al. | Tilmicosin antibacterial activity and pharmacokinetics in cows | |
| US6340469B1 (en) | System for prophylactic treatment of mammary disorders | |
| Leitner et al. | Aetiology of intramammary infection and its effect on milk composition in goat flocks | |
| US3917818A (en) | Treatment of mastitis in cows, the product for this treatment and to the production of said product | |
| Oliver et al. | Prevalence, risk factors, and strategies for controlling mastitis in heifers during the periparturient period | |
| Owens et al. | Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation | |
| Poutrel et al. | Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis | |
| Mella et al. | Evaluation of a new vaccine against Staphylococcus aureus mastitis in dairy herds of southern Chile. I. Challenge trial | |
| Pyörälä et al. | Bovine acute mastitis: Part II. Effect of mastitis pathogen, initial inflammatory reaction and therapy on the outcome of the disease | |
| NO130179B (de) | ||
| Ghobrial et al. | Field Trial to Evaluate Vaccine and Antibiotic for Control of Staph. aureus Mastitis in Dairy cattle, Egypt. | |
| Pyörälä et al. | Inflammatory changes during experimental bovine mastitis induced by Staphylococcus aureus, Streptococcus dysgalactiae and Streptococcus uberis | |
| Guterbock | Rational treatment of clinical mastitis | |
| Semina et al. | Improved measures for the prevention of mass mastitis in cows in the Vologda region farms | |
| CN113069539A (zh) | 一种兔a型、d型多杀性巴氏杆菌和金黄色葡萄球菌三联灭活疫苗及其制备方法 | |
| Luoto et al. | Q Fever Studies in Southern California: XII. Aureomycin treatment of dairy cattle naturally infected with Coxiella burnetii | |
| Langer et al. | Sulfamethazine Blood and Milk Concentrations in Dairy Cows | |
| Podpečan et al. | Treatment of subclinical staphylococcal mastitis |